| |
| |
|
| Insider
Information: |
Bertolini Robert J |
| Relationship: |
Director |
| City: |
Kenilworth |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
43,246 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,805,532 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
43,246 |
|
|
| Total
Value |
$7,805,532 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 110.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Merck & Co Inc |
MRK |
Executive Vice President |
2009-11-03 |
0 |
2009-11-03 |
0 |
Premium* |
|
|
Genzyme Corp |
GENZ |
Director |
2011-04-04 |
0 |
2010-06-16 |
0 |
Premium* |
|
|
Charles River Laboratories Inter... |
CRL |
Director |
2023-05-15 |
31,849 |
2011-02-01 |
0 |
Premium* |
|
|
Bristol-Myers Squibb Co |
BMY |
Director |
2019-07-31 |
11,397 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2023-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,132 |
31,849 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2022-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
980 |
30,717 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
603 |
29,737 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2020-05-20 |
4 |
S |
$174.58 |
$616,263 |
D/D |
(3,530) |
29,134 |
0 |
% |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2020-05-20 |
4 |
OE |
$52.29 |
$184,584 |
D/D |
3,530 |
32,664 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2020-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,259 |
29,134 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2020-02-13 |
4 |
S |
$170.41 |
$1,221,819 |
D/D |
(7,170) |
27,875 |
0 |
% |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2020-02-13 |
4 |
OE |
$43.39 |
$395,572 |
D/D |
7,170 |
35,045 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Director |
– • – |
2019-07-31 |
4 |
B |
$44.72 |
$491,920 |
D/D |
11,000 |
11,397 |
2.39 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2019-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
2,539 |
27,875 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2018-12-04 |
4 |
OE |
$33.93 |
$154,042 |
D/D |
4,540 |
29,876 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2018-12-04 |
4 |
S |
$133.16 |
$460,154 |
D/D |
(3,440) |
26,436 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2018-12-04 |
4 |
S |
$134.19 |
$148,179 |
D/D |
(1,100) |
25,336 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,750 |
25,336 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2018-01-02 |
4 |
AS |
$110.07 |
$397,785 |
D/D |
(3,609) |
22,586 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2018-01-02 |
4 |
AS |
$109.12 |
$452,717 |
D/D |
(4,131) |
26,195 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2018-01-02 |
4 |
OE |
$40.27 |
$311,690 |
D/D |
7,740 |
30,326 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2017-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,436 |
22,586 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2017-03-01 |
4 |
S |
$87.78 |
$592,702 |
D/D |
(6,735) |
20,150 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2017-03-01 |
4 |
S |
$87.27 |
$459,988 |
D/D |
(5,255) |
26,885 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2017-03-01 |
4 |
OE |
$37.81 |
$453,342 |
D/D |
11,990 |
32,140 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Director |
– • – |
2017-02-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
397 |
|
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2016-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,260 |
20,150 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,970 |
17,890 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2014-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,720 |
15,920 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
